Page last updated: 2024-10-27

fluorouracil and Carcinoma, Brown-Pearce

fluorouracil has been researched along with Carcinoma, Brown-Pearce in 1 studies

Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.

Carcinoma, Brown-Pearce: A transplantable EPITHELIAL CELL neoplasm of rabbits.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nagano, T1

Other Studies

1 other study available for fluorouracil and Carcinoma, Brown-Pearce

ArticleYear
[Influence of antineoplastic agents on the tissue respiration in transplanted gastric cancer in rabbits, with special reference to the effects on the growth process of transplanted cancer cells].
    Igaku kenkyu. Acta medica, 1971, Volume: 41, Issue:2

    Topics: Animals; Carcinoma, Brown-Pearce; Cyclophosphamide; Fluorouracil; Glucose; Hydrogen-Ion Concentratio

1971